Eli Lilly and Company developed the drug Retatrutide.
6 reports, 4 independent
Updated Fri 00:00
No new developments lately
- Reports
- 6
- Developments
- 4
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eli Lilly and Company developed the drug Retatrutide.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Retatrutide demonstrates superior efficacy.1 source
Eli Lilly is seeking FDA approval for Retatrutide, with Max Denning serving as an associate vice president.1 source
Lilly is moving its retatrutide candidate into the formal FDA review process.1 source
Eli Lilly announced the development of its new drug, Retatrutide.1 source
Keep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
Related events
- Eli Lilly and Company and BeOne Medicines Ltd. are both identified as major players in the medical sector.
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
- Eli Lilly and Company now owns the drugmaker AtaiBeckley.
- Eli Lilly and Merck are combining therapies in clinical trials.